Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Open accessThe DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in western countries, with a median survival of 6 months and an extremely low percentage of long-term surviving patients. KRAS mutations are known to be a driver event of PDAC, but targeting mutant KRAS has proved challenging. Targeting oncogene-driven signalling pathways is a clinically validated approach for several devastating diseases. Still, despite marked tumour shrinkage, the frequency of relapse indicates that a fraction of tumour cells survives shut down of oncogenic signalling. Here we explore the role of mutant KRAS in PDAC maintenance using a recently developed inducible mouse model of mutated Kras (Kras(G12D), herein KRas) in a p53(LoxP/WT) background. We demonstrate that a subpopulation of dormant tumour cells surviving oncogene ablation (surviving cells) and responsible for tumour relapse has features of cancer stem cells and relies on oxidative phosphorylation for survival. Transcriptomic and metabolic analyses of surviving cells reveal prominent expression of genes governing mitochondrial function, autophagy and lysosome activity, as well as a strong reliance on mitochondrial respiration and a decreased dependence on glycolysis for cellular energetics. Accordingly, surviving cells show high sensitivity to oxidative phosphorylation inhibitors, which can inhibit tumour recurrence. Our integrated analyses illuminate a therapeutic strategy of combined targeting of the KRAS pathway and mitochondrial respiration to manage pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prior studies have demonstrated that genetic ablation of KRAS expression leads to cell cycle arrest and death in cell lines and potent tumor regressions in animal models of PDAC (5–7).”
From Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with this notion, other complex I inhibitors have shown efficacy as anti-tumor agents (Appleyard et al., 2012; Schockel et al., 2015) and may show selective toxicity against oncogene-ablation resistant cells (Viale et al., 2014) and cancer stem cells (Sancho et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recurrent theme in studies on cancer progression is the increased reliance of cancer cells on OXPHOS in advanced stages of disease.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to the proliferating bulk of a tumor, accumulating evidence suggests that quiescent subpopulations of tumor cells are markedly less glycolytic and exhibit higher dependence on oxidative phosphorylation, as well as elevated expression of mitochondrial respiratory components.”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In a mouse pancreatic cancer model, ablating oncogenic Kras from established tumors revealed a fraction of cells that survive and eventually propagate.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Self-citationTransmission Electron Microscopy
Williams, D. B., & Carter, C. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-76501-3 · Cited by 3,963
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Self-citationHematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Self-citation
Cited by
Items 901–1,000 of 1,000
Hafner, P., Keller, S. J., Chen, X., Alrawashdeh, A. Y., Jumaa, H., Nollmann, F. I., Besson, S., Kemming, J., Gorka, O., Das, T., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02563-7 · Cited by 12
Autophagy modulation in cancer
Guilbaud, E., Ryan, K. M., Green, D. R., & Galluzzi, L. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01449-9 · Cited by 15
Smirnova, I. E., Drăghici, G. A., Kazakova, O. B., Vlaia, L. L., Avram, Ș., Mioc, A., Mioc, M., Macasoi, I. G., Dehelean, C. A., Voicu, A., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105535 · Cited by 9
Over-Reduced State of Mitochondria as a Trigger of “β-Oxidation Shuttle” in Cancer Cells
Zhelev, Z., Sumiyoshi, A., Aoki, I., Lazarova, D., Vlaykova, T. I., Higashi, T., & Bakalova, R. (2022) · Cancers · doi:10.3390/cancers14040871 · Cited by 11
Hashimoto, A., Handa, H., Hata, S., & Hashimoto, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005566 · Cited by 11
Deciphering cellular plasticity in pancreatic cancer for effective treatments
Uddin, M. H., Zhang, D., Muqbil, I., El‐Rayes, B. F., Chen, H., Philip, P. A., & Azmi, A. S. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10164-5 · Cited by 11
Wang, X., Breuer, J., Garbe, S., Giordano, F. A., Brossart, P., Feldmann, G., & Bisht, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116249 · Cited by 11
Zikaki, K., Kiachaki, E., Gaitanaki, C., & Aggeli, I.-K. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062435 · Cited by 11
Yamada, K. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00089 · Cited by 10
Marek’s Disease Virus Infection Induced Mitochondria Changes in Chickens
Chu, Q., Ding, Y., Cai, W., Liu, L., Zhang, H., & Song, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133150 · Cited by 10
Progress in therapeutic strategies based on cancer lipid metabolism
Diao, X., & Lin, T. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.13146 · Cited by 9
Cellular Self-Digestion and Persistence in Bacteria
Mohiuddin, S. G., Ghosh, S., Ngo, H. G., Sensenbach, S., Karki, P., Dewangan, N. K., Angardi, V., & Orman, M. A. (2021) · Microorganisms · doi:10.3390/microorganisms9112269 · Cited by 11
Unknown biological effects of l-glucose, ALA, and PUFA
Yamada, K., Sato, D., Nakamura, T., Amano, H., & Morimoto, Y. (2017) · The Journal of Physiological Sciences · doi:10.1007/s12576-017-0544-x · Cited by 13
Myllymäki, H., Kelly, L., Elliot, A. M., Carter, R. N., Johansson, J. A., Chang, K.-M., Cholewa-Waclaw, J., Morton, N. M., & Feng, Y. (2024) · Oncogenesis · doi:10.1038/s41389-024-00507-4 · Cited by 11
Lipids: Driving Forces in the Underlying Biology of Carcinogenesis
Chakraborty, S., Kumar, A. S., & Banerjee, S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00170 · Cited by 10
Giannitti, G., Marchesi, S., Garavaglia, R., Preosto, I., & Fontana, F. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189450 · Cited by 12
Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor
Li, J., Guo, S., Sun, Z., & Fu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.808591 · Cited by 12
Qin, R., Huang, Y., Yao, Y., Wang, L., Zhang, Z., Huang, W., Su, Y., Zhang, Y., Guan, A., & Wang, H. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23376 · Cited by 8
Self-citationPredominant factors influencing reactive oxygen species in cancer stem cells
Soundararajan, L., Warrier, S. R., Dharmarajan, A., & Bhaskaran, N. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30506 · Cited by 10
Sharma, V., Arora, A., Bansal, S., Semwal, A., Sharma, M., & Aggarwal, A. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3920 · Cited by 8
Korhan, P., Verkerk, R. M., & Critchley, W. R. (2017) · Integrative Molecular Medicine · doi:10.15761/imm.1000310 · Cited by 9
Yang, J., Guo, F., Yuan, L., Lv, G., Gong, J., & Chen, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28448 · Cited by 8
Metabolic Stress Adaptations Underlie Mammary Gland Morphogenesis and Breast Cancer Progression
Wang, C. (2021) · Cells · doi:10.3390/cells10102641 · Cited by 11
Therapeutic targeting of dormant cancer stem cells in solid tumors
Ismaeel, G. L., AbdulHussein, A. H., Qasim, H. M., Abed, N. K., Jalil, A. T., Suleiman, A. A., & Dilfy, S. H. (2022) · Gene Reports · doi:10.1016/j.genrep.2022.101717 · Cited by 10
Song, L., Wei, X., Zhang, X., & Lu, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1241454 · Cited by 8
Wu, Y., Chang, Y., Polton, G. A., Stell, A. J., Szladovits, B., Macfarlane, M. J., Peters, L. M., Priestnall, S. L., Bacon, N. J., Kow, K. Y., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00307 · Cited by 10
Metformin turns off the metabolic switch of pancreatic cancer
Deschênes‐Simard, X., Rowell, M., & Ferbeyre, G. (2019) · Aging · doi:10.18632/aging.102622 · Cited by 11
Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancerPreprint
Curiel-Garcia, A., Holmstrom, S. R., Castillo, C., Palermo, C. F., Sastra, S. A., Andren, A. C., Tomassoni, L., Zhang, L., Large, T. Y. S. L., Sagalovskiy, I. R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.19.533333 · Cited by 9
Self-citationMetabolic vulnerability of cancer stem cells and their niche
Marrone, L., Romano, S., Malasomma, C., Giacomo, V. D., Cerullo, A., Abate, R., Vecchione, M. A., Fratantonio, D., & Romano, M. F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1375993 · Cited by 7
Phospholipid Metabolism Reprogramming of Cancer Stem Cells and Its Impacts on Stemness
Wang, Q., Cai, L., Tang, S., Pan, D., Wang, Z., Chen, Q., Zhou, Y., & Shen, Y. (2025) · Biocell · doi:10.32604/biocell.2025.060045 · Cited by 8
Integrative genomic identification of therapeutic targets for pancreatic cancer
Guo, J. A., Gong, D. H., Evans, K. E., Takahashi, K., Jambhale, A. D., Shiau, C., Yu, P. Z., Wang, S., Wu, W., Chugh, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116191 · Cited by 9
Rojas, M., Manzi, M., Madurga, S., Velásquez, F. E. G., Romero, M. A., Marín, S., Cascante, M., & Maurel, J. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002337 · Cited by 8
Liu, T., Sun, S., Huang, Y., Yiming, E., Li, W., Xu, F., Liu, Z., Luo, X., Chen, L., & Yu, C. (2025) · Cancer & Metabolism · doi:10.1186/s40170-025-00408-z · Cited by 11
Mbah, N. E., Sutton, D., Hong, H. S., Singhal, R., Menjivar, R. E., Perricone, M. D., Giza, H., Sajjakulnukit, P., Myers, A. L., Nwosu, Z. C., et al. (2026) · Cancer & Metabolism · doi:10.1186/s40170-026-00428-3 · Cited by 9
Self-citationSighel, D., Battistini, G., Rosatti, E. F., Vigna, J., Pavan, M., Belli, R., Peroni, D., Alessandrini, F., Longhi, S., Pancher, M., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114979 · Cited by 7
LncRNAs and asymmetric cell division: The epigenetic mechanisms
Chen, H., & Wu, K. (2024) · Biomedical Journal · doi:10.1016/j.bj.2024.100774 · Cited by 8
Morgenstern, Y., Lee, J. B., Na, Y., Lieng, B. Y., Ly, N. S., Gwynne, W. D., Hurren, R., Ma, L., Ling, D., Gronda, M., et al. (2024) · Haematologica · doi:10.3324/haematol.2024.286018 · Cited by 9
Zhou, C., Chen, Y., Chen, S., Hu, L., Wang, J., & Wang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1491910 · Cited by 7
Self-citationRASpecting the oncogene: New pathways to therapeutic advances
Stout, M. C., & Campbell, P. M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.10.022 · Cited by 7
Sankarasubramanian, S., Pfohl, U., Regenbrecht, C. R. A., Reinhard, C., & Wedeken, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.760705 · Cited by 7
Trends in metabolic signaling pathways of tumor drug resistance: A scientometric analysis
Jiang, R., Cao, M., Mei, S., Guo, S., Zhang, W., Ji, N., & Zhao, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.981406 · Cited by 10
Zhu, H., Chen, Q., Zhao, L., & Hu, P. (2023) · Nutrition and Cancer · doi:10.1080/01635581.2023.2180825 · Cited by 7
Mooney, B., Raof, N. A., Tian, Y. I., & Xie, Y. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00237 · Cited by 7
Yu, J. C., Zhang, Y., Zhou, D., Wu, J., & Luo, R. (2018) · Oncology Letters · doi:10.3892/ol.2018.8685 · Cited by 11
Inokuchi, S., Itoh, S., Yoshizumi, T., Yugawa, K., Yoshiya, S., Toshima, T., Takeishi, K., Iguchi, T., Sanefuji, K., Harada, N., et al. (2020) · Pancreatology · doi:10.1016/j.pan.2020.07.011 · Cited by 7
Nguyen, T. T., Gapihan, G., Tétu, P., Pamoukdjian, F., Bouchtaoui, M. E., Lebœuf, C., Feugeas, J., Paris, J., Baroudjian, B., Delyon, J., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.198 · Cited by 10
Circular RNAs in neuroblastoma: Pathogenesis, potential biomarker, and therapeutic target
Fath, M. K., Benam, S. P., Salmani, K., Naderi, S., Fahham, Z., Ghiabi, S., Kia, S. A. H., Naderi, M., Darvish, M., & Barati, G. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154094 · Cited by 8
Flavinated SDHA underlies the change in intrinsic optical properties of oral cancers
Marumo, T., Maduka, C. V., Ural, E. E., Apu, E. H., Chung, S., Tanabe, K., van den Berg, N. S., Zhou, Q., Martin, B. A., Miura, T., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05510-w · Cited by 6
Clonal Heterogeneity Supports Mitochondrial Metabolism in Pancreatic CancerPreprint
Halbrook, C. J., Thurston, G., McCarthy, A., Nelson, B. S., Sajjakulnukit, P., Krall, A. S., Mullen, P. J., Zhang, L., Batra, S., Viale, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.15.098368 · Cited by 9
Self-citationMitochondrial inflexibility ignites tumor immunogenicity in postoperative glioblastoma
Cheng, L., Fang, Z., Wang, J., Xi, K., Zhang, Y., Feng, F., Yu, L., Santiago-Bautista, M. R., Wang, J., Wu, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62244-5 · Cited by 12
Oza, V. D., Flores, K. A., Chernyavskaya, Y., Al‐Hamaly, M. A., Smith, C. B., Bruntz, R. C., & Blackburn, J. S. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70188 · Cited by 9
Liu, X., Liu, J., Zhou, Y., Li, M., Wang, F., Jiang, G., Xiao, Y., Cui, W., Jiang, M., Gu, L., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08278-5 · Cited by 8
Oliveres, H., Cascante, M., & Maurel, J. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102401 · Cited by 7
Khamari, R., Degand, C., Fovez, Q., Trinh, A., Chomy, A., Laine, W., Dekiouk, S., Ghesquière, B., Quesnel, B., Marchetti, P., et al. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104253 · Cited by 6
Zhou, S., Ze, X., Feng, D., Liu, L., Shi, Y., Yu, M., Huang, L., Wang, Y., Men, H., Wu, J., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01178 · Cited by 7
Self-citationGoing Rogue: Mechanisms, Regulation, and Roles of Mutationally Activated Gα in Human Cancer
Dwyer, M. B., Aumiller, J. L., & Wedegaertner, P. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000743 · Cited by 6
Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis
Preston, S. E. J., Dahabieh, M. S., González, R. E. F., Gonçalves, C., Richard, V. R., Leibovitch, M., Dakin, E., Papadopoulos, T., Naranjo, C. L., McCallum, P. A., et al. (2024) · Science Advances · doi:10.1126/sciadv.adi7673 · Cited by 8
DAZAP1 maintains gastric cancer stemness by inducing mitophagy
Zhang, P., Wang, W. T., Xiang, H. P., Zhou, Y., Peng, Q., Liu, G., Xu, Z., & Lü, L. (2025) · JCI Insight · doi:10.1172/jci.insight.175422 · Cited by 9
Oncogenic dependency plays a dominant role in the immune response to cancer
Li, J., D’Amico, S., Kirillov, V., Petrenko, O., & Reich, N. C. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2308635120 · Cited by 6
Exploring Signaling Pathways and Pancreatic Cancer Treatment Approaches Using Genetic Models
Khader, S. T. S. A., Thyagarajan‐Sahu, A., & Sahu, R. P. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666190327163644 · Cited by 8
Sapio, L., Ragone, A., Spina, A., Salzillo, A., & Naviglio, S. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2022.34 · Cited by 6
Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go?
Grapsa, D., Saif, M. W., & Syrigos, K. (2015) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v7.i10.172 · Cited by 6
Bosc, C., Gadaud, N., Bousard, A., Sabatier, M., Cognet, G., Saland, E., Farge, T., Boët, E., Gotanègre, M., Aroua, N., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.17.253856 · Cited by 6
Shojaei, S., Basso, J., Amereh, M., Alizadeh, J., Dehesh, T., Rosa, S. C. D. S., Clark, C. J., Hassan, M., Tomczyk, M., Cole, L., et al. (2022) · Research Square · doi:10.1101/2022.10.29.514383 · Cited by 7
Sarkar, S., & Suresh, P. K. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1701031 · Cited by 6
Hadi, N. A., Reyes‐Castellanos, G., Gicquel, T., Gallardo-Arriaga, S., Cosialls, E., Boët, E., Sarry, J., Masoud, R., Iovanna, J., & Carrier, A. (2025) · Oncogenesis · doi:10.1038/s41389-025-00591-0 · Cited by 6
Lin, Q., Morales-Giron, A. A., Sander, C., Curtis, J. M., Barnes, H., Patel, P. S., de la Cruz, F. F., Riedl, J. M., Matsubara, H., Nakamura, H., et al. (2026) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-1788 · Cited by 10
McAndrews, K. M., Mahadevan, K. K., Li, B., Comptdaer, A. M., Sockwell, A. M., Morse, S. J., Kelly, P. J., Patel, S. I., Kirtley, M. L., Diaz, B. A. M., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00854-5 · Cited by 12
Self-citationGuo, F., Yang, H., Li, S., Jiang, Y., Bai, X., Hu, C., Li, W., & Han, W. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108598 · Cited by 5
Amereh, M., Seyfoori, A., Shojaei, S., Lane, S., Zhao, T., Barough, M. S., Lum, J. J., Walter, P. B., & Akbari, M. (2025) · Advanced Science · doi:10.1002/advs.202412505 · Cited by 7
Spectrum of mitochondrial genomic variation in parathyroid neoplasms
Hu, Y., Zhang, X., Wang, O., Xing, X., Cui, M., Wang, M., Song, C., & Liao, Q. (2021) · Endocrine · doi:10.1007/s12020-021-02825-8 · Cited by 5
Comparative Untargeted Metabolomic Profiling of Induced Mitochondrial Fusion in Pancreatic Cancer
Nguyen, N. D., Yu, M., Reddy, V. Y., Acevedo-Diaz, A., Mesarick, E. C., Jaoude, J. A., Yuan, M., Asara, J. M., & Taniguchi, C. M. (2021) · Metabolites · doi:10.3390/metabo11090627 · Cited by 5
Self-citationIn vitro assessment of stearyl triphenyl phosphonium toxicity in drug-resistant tumor cells
Shah, S., Ouellette, M., & D’Souza, G. G. M. (2022) · 4open · doi:10.1051/fopen/2022003 · Cited by 5
GPD2: The relationship with cancer and neural stemness
Mikeli, M., Fujikawa, M., & Tanabe, T. (2022) · Cells and Development · doi:10.1016/j.cdev.2022.203824 · Cited by 5
In search for symmetries in the metabolism of cancer
Gatto, F., & Nielsen, J. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1321 · Cited by 6
Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma
Ye, F., Jia, D., Lu, M., Levine, H., & Deem, M. W. (2018) · Oncotarget · doi:10.18632/oncotarget.24551 · Cited by 5
RAS: Circuitry and therapeutic targeting
Singh, G., Thakur, N., & Kumar, U. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110505 · Cited by 7
Metabolic vulnerability in tumours illuminated
Rao, A. D., & DeBerardinis, R. J. (2019) · Nature · doi:10.1038/d41586-019-03239-3 · Cited by 6
The Impact of [C16Pyr][Amp] on the Aggressiveness in Breast and Prostate Cancer Cell Lines
Vieira, F. Q., Marques-Magalhães, Â., Miranda‐Gonçalves, V., Ferraz, R., Vieira, M., Prudêncio, C., Jerónimo, C., & Silva, R. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249584 · Cited by 5
KLF 6: a mitochondrial regulator in the kidney
Mallipattu, S. K., & He, C. (2015) · Oncotarget · doi:10.18632/oncotarget.4647 · Cited by 5
Targeting Minimal Residual Disease
Chou, Y., Allegakoen, P., & Bivona, T. G. (2024) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070924-120742 · Cited by 7
Exploring the oncogenic impact of heteroplasmic de novo MT-ND5 truncating mutations
Wu, Y., Ye, J., & Gu, Z. (2025) · Mitochondrial Communications · doi:10.1016/j.mitoco.2025.03.001 · Cited by 4
The Warburg Effect Redefined: A Kinetic and Regulatory Perspective
Vayakkattil, A. B., Pazhanchery, A. S., Andrews, S., & Vayakkattil, U. (2025) · Cureus · doi:10.7759/cureus.93331 · Cited by 13
Mitochondrial Metabolism as a Potential Novel Therapeutic Target for Lung Adenocarcinoma
Fujiwara, M., Mimae, T., Kushitani, K., Tsubokawa, N., Miyata, Y., Takeshima, Y., & Okada, M. (2024) · Anticancer Research · doi:10.21873/anticanres.17352 · Cited by 7
Impacts of Radiation on Metabolism and Vascular Cell Senescence
Abe, J., Chau, K., Mojiri, A., Wang, G., Oikawa, M., Samanthapudi, V. S. K., Osborn, A. M., Ostos-Mendoza, K. C., Mariscal-Reyes, K. N., Mathur, T., et al. (2025) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0741 · Cited by 4
Li, M., Dai, L., Chen, S., Deng, M., Wang, L., & Sun, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1578927 · Cited by 7
Silva, H. M., & Rosa, R. C. A. (2025) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-025-00323-w · Cited by 5
Andrzejewski, S., Winter, M., Garcia, L. E., Akinrinmade, O. A., Marques, F. M., Zacharioudakis, E., Skwarska, A., Aguirre‐Ghiso, J. A., Konopleva, M. Y., Zheng, G., et al. (2025) · Cells · doi:10.3390/cells14191557 · Cited by 6
Porcelli, G., D’Accardo, C., Angeloro, F., Cucchiara, M., Bianca, P., Pantina, V. D., Roozafzay, N., Modica, C., Gaggianesi, M., Bella, S. D., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02499-0 · Cited by 7
Quenching thirst with poison? Paradoxical effect of anticancer drugs
Chai, K., Wang, C., Zhou, J., Mu, W., Gao, M., Fan, Z., & Lv, G. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106987 · Cited by 11
Brandeburg, Z. C., Adio, W. S., Derewonko, C. A., Dunn, C. E., Pfeiffer, E. C., Flusche, A. M., Sheaff, R. J., & Lamar, A. A. (2024) · ChemMedChem · doi:10.1002/cmdc.202400536 · Cited by 4
The systemic evolutionary theory of the origin of cancer (SETOC): an update
Mazzocca, A., Ferraro, G., & Misciagna, G. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01069-w · Cited by 7
Saeed, M. U., Hussain, N., Zulfiqar, I., Raza, A., Ghauri, M. A., & Bilal, M. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103645 · Cited by 4
Song, M., Lu, Q., Xu, M., Li, Y., Zhao, Y., Chen, G., & Ou, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.987026 · Cited by 5
Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers
Singh, N., Romick‐Rosendale, L. E., Watanabe‐Chailland, M., Vinnedge, L. M. P., & Komurov, K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0256788 · Cited by 4
PPAR/PDK4 pathway is involved in the anticancer effects of cGMP in pancreatic cancer
Yamashita, M., Kumazoe, M., Onda, H., Hiroi, S., Shimada, Y., Fujimura, Y., & Tachibana, H. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.06.043 · Cited by 6
Mitochondrial dysfunction in breast cancer
Germain, D., Papa, L., Kenny, T. C., Takabatake, Y., & Riar, A. K. (2015) · Research and Reports in Biology · doi:10.2147/rrb.s62507 · Cited by 4
Subedi, A., Muroi, M., Futamura, Y., Kawamura, T., Aono, H., Nishi, M., Ryo, A., Watanabe, N., & Osada, H. (2019) · FEBS Letters · doi:10.1002/1873-3468.13361 · Cited by 4
Methodological Approaches for Assessing Metabolomic Changes in Glioblastomas
Nguyen, T. T. T., Shang, E., Westhoff, M., Karpel‐Massler, G., & Siegelin, M. D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2071-7_19 · Cited by 4
Autophagy-Driven Cancer Drug Development
Belaïd, A., Roméo, B., Filippakis, H., Meyer, M., Grosjean, I., Yazbeck, N., Domdom, M. A., Crépeaux, G., Gherardi, R. K., Lagadic‐Gossmann, D., et al. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805253-2.00021-3 · Cited by 4
Metadata
- Authors
- Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., Kost-Alimova, M., Muller, F., Colla, S., Nezi, L., Genovese, G., Deem, A. K., Kapoor, A., Yao, W., Brunetto, E., Kang, Y., Yuan, M., Asara, J. M., Wang, Y. A., Heffernan, T. P., Kimmelman, A. C., Wang, H., Fleming, J. B., Cantley, L. C., DePinho, R. A., & Draetta, G. F.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Weill Cornell Medicine (US)
- IRCCS Ospedale San Raffaele (IT)
- Beth Israel Deaconess Medical Center (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Viale, Andrea
- Draetta, Giulio F.
- ORCID
- Viale, Andrea
- Pettazzoni, Piergiorgio
- Lyssiotis, Costas A.
- Ying, Haoqiang
- Sánchez, Nora
- Marchesini, Matteo
- Carugo, Alessandro
- Seth, Sahil
- Giuliani, Virginia
- Colla, Simona
- Nezi, Luigi
- Genovese, Giannicola
- Deem, Angela K.
- Yao, Wantong
- Brunetto, Emanuela
- Kang, Ya’an
- Yuan, Min
- Asara, John M.
- Wang, Y. Alan
- Heffernan, Timothy P.
- Kimmelman, Alec C.
- Wang, Huamin
- Fleming, Jason B.
- Cantley, Lewis C.
- DePinho, Ronald A.
- Draetta, Giulio F.
- Venue
- Nature
- Published
- 2014-08-10
- Volume
- 514
- Issue
- 7524
- Pages
- 628-632
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4376130
- OpenAlex
- W2023300506
- Semantic Scholar
- 819eeeb41f6e84dd5c00221a269e91238736c4ad
- Cited by
- 1,259
- References
- 125
- Citations by year
- 2026: 93 · 2025: 72 · 2024: 104 · 2023: 105 · 2022: 119 · 2021: 131 · 2020: 135 · 2019: 114 · 2018: 105 · 2017: 90 · 2016: 99 · 2015: 81 · 2014: 8
- FWCI
- 44.61
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-08)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA127003, CA-16672, CA 016672, P01CA120964, P30CA016672, P01CA117969)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, KRAS mutation, tumor recurrence, oxidative phosphorylation, mitochondrial respiration, cancer stem cells, autophagy, glycolysis, OXPHOS inhibitors, combination therapy
- MeSH terms
- Animals, Autophagy, Cell Survival, Disease Models, Animal, Female, Glycolysis, Lysosomes, Mitochondria, Mutation, Neoplasm Recurrence, Local, Oxidative Phosphorylation, Pancreatic Neoplasms, Recurrence, Neoplastic Stem Cells, Signal Transduction, Gene Expression Regulation, Neoplastic, Genes, p53, Proto-Oncogene Proteins p21(ras), Cell Respiration, Carcinoma, Pancreatic Ductal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.